Skip to main content
Premium Trial:

Request an Annual Quote

Biofortuna AmpDRY Air-Dried Master Mix

Biofortuna announced today that it will launch its ampDRY master mix for PCR applications at the American Association for Clinical Chemistry Annual Scientific Meeting and Clinical Lab Expo 2018. The firm has developed its ampDRY hot-start master mix to allow complete endpoint or real-time PCR assays to be stabilized in a dry format at ambient temperatures for at least 12 months. Biofortuna said that it also offers full in vitro diagnostic contract manufacturing services using ampDRY, and can customize the manufacturing process to match customer requirements and develop bespoke, cost-effective stabilized products. 

The Scan

Quality Improvement Study Compares Molecular Tumor Boards, Central Consensus Recommendations

With 50 simulated cancer cases, researchers in JAMA Network Open compared molecular tumor board recommendations with central consensus plans at a dozen centers in Japan.

Lupus Heterogeneity Highlighted With Single-Cell Transcriptomes

Using single-cell RNA sequencing, researchers in Nature Communications tracked down immune and non-immune cell differences between discoid lupus erythematosus and systemic lupus erythematosus.

Rare Disease Clues Gleaned From Mobile Element Insertions in Exome Sequences

With an approach called MELT, researchers in the European Journal of Human Genetics uncovered mobile element insertions in exomes from 3,232 individuals with or without developmental or neurological abnormalities.

Team Tracks Down Potential Blood Plasma Markers Linked to Heart Failure in Atrial Fibrillation Patients

Researchers in BMC Genomics found 10 differentially expressed proteins or metabolites that marked atrial fibrillation with heart failure cases.